Why is cycloserine so expensive?

Cycloserine (Cycloserine) is one of the key drugs in anti-tuberculosis treatment, and its price varies greatly in different markets. Domestic cycloserine has been launched and included in Class B medical insurance. The common specification is 250 mg 10 tablets. The medical insurance payment price per box is relatively low, which may range from tens to hundreds of yuan. However, prices in overseas markets are significantly higher than domestic prices, especially for generic drugs produced in countries such as India. Each box of 250mg 60 tablets is priced at more than 400 yuan, which fluctuates greatly due to exchange rates and market supply.

Price differences are primarily due to drug production costs, market demand and drug supply chain complexity. Cycloserine is a synthetic drug with a relatively complex production process that requires strict quality control and stable purity, which increases production costs. In addition, this drug is mainly used for drug-resistant tuberculosis and special treatment programs. The demand is relatively limited, and the mass production efficiency is low, making the cost of a single tablet high. Foreign original drugs and some generic drugs must undergo strict registration and export approval, further increasing market prices.

Another influencing factor is drug patent and regulatory policy. Original drugs are still subject to patent protection or market access restrictions in some countries, but in China, inclusion in medical insurance and local production make the price relatively low and reduce the financial burden on patients. It is worth noting that although different specifications have different prices, the ingredients and efficacy of the drugs are basically the same. When choosing, patients should take into account doctor's guidance, accessibility and medical insurance policies.

Therefore, the price of cycloserine is not determined by a single factor, but is the result of a combination of production costs, market supply, patent status and medical insurance policies. In clinical use, rational selection of specifications, utilization of medical insurance policies, and attention to drug channels can ensure the therapeutic effect while reducing the economic burden.

Reference materials:https://en.wikipedia.org/wiki/Cycloserine